6min chapter

Diabetes Core Update cover image

Diabetes Core Update – February 2023

Diabetes Core Update

CHAPTER

Glucagon Increases Energy Expenditure

Terzepitide, a combination dual receptor agonist GLP one GIP and low and behold in the surmount trial last year, June in people with obesity and without diabetes 22% weight loss. glucagon for years has been like that medical student that you know has a lot of potential, but it just he hasn't matured yet. And we'll see how this combination peptide does long term through many other phases,. But it's very exciting we might have an even more powerful triple receptor agonist in the future.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode